HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Panretinal photocoagulation in central retinal vein occlusion: A randomised controlled clinical study.

Abstract
A randomised controlled study of photocoagulation compared with no treatment in central retinal vein occlusion is reported. Forty-eight patients were allocated into treated and control groups by a random procedure 3 months after their first visual symptoms. For the analysis they were subdivided into (1) ischaemic type, and (2) hyperpermeability-response macular-oedema type of central retinal vein occlusion. In neither group did treatment confer benefit as far as visual acuity was concerned. However, iris, disc, and retinal neovascularisation improved after treatment in the ischaemic group. In addition none of the treated patients progressed to neovascular glaucoma. Macular-oedema improved in treated patients with the hyperpermeability response, but the visual field was affected and atrophic changes at the macular precluded visual improvement. It is concluded that photocoagulation should be used only to prevent complications in the ischaemic type of central retinal vein occlusion. It does not appear to be of value in the hyperpermeability group.
AuthorsL Laatikainen, E M Kohner, D Khoury, R K Blach
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 61 Issue 12 Pg. 741-53 (Dec 1977) ISSN: 0007-1161 [Print] England
PMID341965 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Topics
  • Adult
  • Aged
  • Clinical Trials as Topic
  • Constriction, Pathologic (surgery)
  • Humans
  • Ischemia (surgery)
  • Light Coagulation
  • Macular Degeneration (surgery)
  • Middle Aged
  • Retina (surgery)
  • Retinal Vein
  • Visual Acuity
  • Visual Fields

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: